Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Traditional gene editing rewrites DNA. But a new approach, called epigenome editing, aims to treat the molecular scars we collect throughout our lives.
Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.
Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.
The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now itβs at the center of a rapidly widening epidemic in Africa.
Clinical trials in China are getting attention at an international oncology gathering in Chicago. Chinaβs surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
The babies were part of a vaccine trial for a respiratory virus in the 1960s and died shortly after. Their families said they had been unaware of the trial until recently.